CRMD (CorMedix Inc.) Short-Term Debt to Capital

The price chart for CorMedix Inc. (CRMD) reflects the performance of a company that has developed an advanced method for combating sepsis during dialysis by blocking pathogens in catheters. The current value of the metric is 0.00, with profits driven by the rate of the drug's clinical expansion and insurance reimbursements. Its high status as an innovator in protecting patients from hospital-acquired infections confirms exceptional physician trust in the brand.

This indicator compares obligations with a maturity of up to one year against equity, allowing for an assessment of the risk of a liquidity gap and the issuer's overall solvency. By analyzing the trend of short-term debt-to-equity, an investor determines the resilience of CorMedix Inc. (CRMD) to sudden stock price drops, which is critical when financing the automation of filling lines and the digitalization of clinical trial audits.